ICBLS2026

2026第十四届生物与生命科学国际会议

会议时间:2026年12月12-14日会议地点:中国,厦门

会议网址:http://www.icbls.net/2026/12/cn/home

演讲嘉宾

2026第十四届生物与生命科学国际会议(ICBLS2026)演讲嘉宾信息如下:

Dr. Shufeng Zhou, Professor

College of Chemical Engineering, Huaqiao University, Xiamen, China

Biography

Dr. Shu-Feng Zhou is a Distinguished Professor and doctoral supervisor at Huaqiao University, where he previously served as Dean of the College of Chemical Engineering. He has held academic, research, and leadership positions at the University of Auckland, National University of Singapore, Queensland University of Technology, RMIT University, and the University of South Florida (USF). At USF, he served as Associate Dean of the College of Pharmacy, Chair of the Department of Pharmaceutical Sciences, and Associate Vice President. His research focuses on drug discovery and development, drug metabolism and transport, nanomedicine, biochemical engineering, and precision medicine. Recognized repeatedly as a Clarivate Highly Cited Researcher, he has published more than 650 SCI-indexed papers, with over 65,000 citations and an h-index of 107, and has edited or contributed to 19 English-language scholarly books. He has secured more than US$65 million in cumulative research funding and mentored 42 postdoctoral researchers, 58 PhD students, and more than 120 master's students. His honors include appointments under national high-level international talent programs and Fujian Province's Hundred Foreign Experts Program. He has also served on an expert committee of the International Agency for Research on Cancer (IARC/WHO) and as a reviewer for major research and talent programs.

Topic

Targeting Kinases and Regulated Cell Death: New Strategies for Precision Cancer Therapy

Abstract

Targeted cancer therapy has evolved from inhibiting a single oncogene or signaling pathway toward coordinated interventions involving multiple targets and mechanisms. This presentation highlights our investigations into the design of tyrosine kinase inhibitors (TKIs) and the induction of regulated cell death. Novel small-molecule TKIs were designed and synthesized using kinase ATP-binding sites and fragment-based strategies, followed by evaluation of their antitumor activities and molecular targets. We also developed tumor-targeted nanodelivery systems designed to induce ferroptosis by increasing intracellular iron, promoting reactive oxygen species (ROS) generation, and downregulating GPX4. To trigger copper-dependent cell death (cuproptosis), we engineered near-infrared (NIR)-driven CuSiO3@Au–Pd micro/nanomotors for deeper tumor penetration. These systems perturb copper homeostasis, deplete glutathione (GSH), generate ROS, reduce mitochondrial membrane potential, and promote DLAT aggregation. Integrating TKI-mediated signaling inhibition with ferroptosis and cuproptosis may offer new approaches to overcoming therapeutic resistance and developing mechanism-based combination treatments in precision oncology.

huiyi123是一个专业提供国际学术会议交流、学术论文出版的平台。会议接受中文和英文文章,提供30-60天快速在线出版。会议在上海,青岛,杭州,南京,成都,西安,武汉,苏州,济南等城市举办。

联系我们

添加组委会微信
(王老师)

添加组委会微信
(周老师)

Copyright © 2015-上海来溪会务服务有限公司 版权所有 沪ICP备16000615号-1

沪公网安备 31010702005021号